177 related articles for article (PubMed ID: 38105176)
21. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
[TBL] [Abstract][Full Text] [Related]
22. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
[TBL] [Abstract][Full Text] [Related]
23. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
24. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
[TBL] [Abstract][Full Text] [Related]
25. Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
Ferrer-Avargues R; Castillejo MI; Dámaso E; Díez-Obrero V; Garrigos N; Molina T; Codoñer-Alejos A; Segura Á; Sánchez-Heras AB; Castillejo A; Soto JL
Cancer Commun (Lond); 2021 Mar; 41(3):218-228. PubMed ID: 33630411
[TBL] [Abstract][Full Text] [Related]
26. Genetic testing in families with hereditary colorectal cancer in British Columbia and Yukon: a retrospective cross-sectional analysis.
Beard VK; Bedard AC; Nuk J; Lee PWC; Hong Q; Bedard JEJ; Sun S; Schrader KA
CMAJ Open; 2020; 8(4):E637-E642. PubMed ID: 33077534
[TBL] [Abstract][Full Text] [Related]
27. Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis.
Ahsan MD; Levi SR; Webster EM; Bergeron H; Lin J; Narayan P; Nelson BB; Li X; Fowlkes RK; Brewer JT; Thomas C; Christos PJ; Chapman-Davis E; Cantillo E; Holcomb K; Sharaf RN; Frey MK
PEC Innov; 2023 Dec; 2():100138. PubMed ID: 37214514
[TBL] [Abstract][Full Text] [Related]
28. Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation.
Blasi PR; Scrol A; Anderson ML; Gray MF; Tiffany B; Fullerton SM; Ralston JD; Leppig KA; Henrikson NB
Pilot Feasibility Stud; 2022 Aug; 8(1):174. PubMed ID: 35945632
[TBL] [Abstract][Full Text] [Related]
29. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
[TBL] [Abstract][Full Text] [Related]
30. A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.
Cock-Rada AM; Ossa CA; Garcia HI; Gomez LR
Fam Cancer; 2018 Jan; 17(1):23-30. PubMed ID: 28528518
[TBL] [Abstract][Full Text] [Related]
31. The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives.
Skasko E; Paszko Z; Niwińska A; Kwiatkowska E; Kruczek A; Pieńkowski T
Eur J Gynaecol Oncol; 2004; 25(4):470-4. PubMed ID: 15285306
[TBL] [Abstract][Full Text] [Related]
32. The Michigan Genetic Hereditary Testing (MiGHT) study's innovative approaches to promote uptake of clinical genetic testing among cancer patients: a study protocol for a 3-arm randomized controlled trial.
Gerido LH; Griggs JJ; Resnicow K; Kidwell KM; Delacroix E; Austin S; Hanson EN; Bacon E; Koeppe E; Goodall S; Demerath M; Rizzo EA; Weiner S; Hawley ST; Uhlmann WR; Roberts JS; Stoffel EM
Trials; 2023 Feb; 24(1):105. PubMed ID: 36765432
[TBL] [Abstract][Full Text] [Related]
33. Extended Family Outreach in Hereditary Cancer Using Web-Based Genealogy, Direct-to-Consumer Ancestry Genetics, and Social Media: Mixed Methods Process Evaluation of the ConnectMyVariant Intervention.
Chen AT; Huey J; Coe S; Kaganovsky J; Malouf EA; Evans HD; Daker J; Harper E; Fordiani O; Lowe EE; Oldroyd CM; Price A; Roth K; Stoddard J; Crandell JN; Shirts BH
JMIR Cancer; 2023 Apr; 9():e43126. PubMed ID: 37079361
[TBL] [Abstract][Full Text] [Related]
34. Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study.
Kim S; Aceti M; Baroutsou V; Bürki N; Caiata-Zufferey M; Cattaneo M; Chappuis PO; Ciorba FM; Graffeo-Galbiati R; Heinzelmann-Schwarz V; Jeong J; Jung MM; Kim SW; Kim J; Lim MC; Ming C; Monnerat C; Park HS; Park SH; Pedrazzani CA; Rabaglio M; Ryu JM; Saccilotto R; Wieser S; Zürrer-Härdi U; Katapodi MC
JMIR Res Protoc; 2021 Jun; 10(6):e26264. PubMed ID: 34114954
[TBL] [Abstract][Full Text] [Related]
35. Impact of BRCA1/2 cascade testing on anxiety, depression, and cancer worry levels among unaffected relatives in a multiethnic Asian cohort.
Padmanabhan H; Mariapun S; Lee SY; Hassan NT; Lee DS; Meiser B; Wong SW; Lee YQ; Yip CH; Teo SH; Thong MK; Taib NAM; Yoon SY
J Genet Couns; 2023 Feb; 32(1):43-56. PubMed ID: 35913122
[TBL] [Abstract][Full Text] [Related]
36. A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocol.
Petrocchi S; Ongaro G; Calvello M; Feroce I; Bonanni B; Pravettoni G
PLoS One; 2022; 17(4):e0266327. PubMed ID: 35395021
[TBL] [Abstract][Full Text] [Related]
37. From Probands to Relatives: Communication of Genetic Risk for Hereditary Breast-Ovarian Cancer and Its Influence on Subsequent Testing.
Seven M; Shah LL; Yazici H; Daack-Hirsch S
Cancer Nurs; 2022 Jan-Feb 01; 45(1):E91-E98. PubMed ID: 32804756
[TBL] [Abstract][Full Text] [Related]
38. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing.
Terdiman JP; Gum JR; Conrad PG; Miller GA; Weinberg V; Crawley SC; Levin TR; Reeves C; Schmitt A; Hepburn M; Sleisenger MH; Kim YS
Gastroenterology; 2001 Jan; 120(1):21-30. PubMed ID: 11208710
[TBL] [Abstract][Full Text] [Related]
39. Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.
Montgomery SV; Barsevick AM; Egleston BL; Bingler R; Ruth K; Miller SM; Malick J; Cescon TP; Daly MB
Fam Cancer; 2013 Sep; 12(3):537-46. PubMed ID: 23420550
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of the
Kinnamon DD; Jordan E; Haas GJ; Hofmeyer M; Kransdorf E; Ewald GA; Morris AA; Owens A; Lowes B; Stoller D; Tang WHW; Garg S; Trachtenberg BH; Shah P; Pamboukian SV; Sweitzer NK; Wheeler MT; Wilcox JE; Katz S; Pan S; Jimenez J; Aaronson KD; Fishbein DP; Smart F; Wang J; Gottlieb SS; Judge DP; Moore CK; Mead JO; Huggins GS; Ni H; Burke W; Hershberger RE;
Circulation; 2023 Apr; 147(17):1281-1290. PubMed ID: 36938756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
